Ken Griffin Sonoma Pharmaceuticals, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sonoma Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 195,157 shares of SNOA stock, worth $804,046. This represents 0.0% of its overall portfolio holdings.
Number of Shares
195,157Holding current value
$804,046% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding SNOA
# of Institutions
19Shares Held
435KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA86.6KShares$356,9730.0% of portfolio
-
Jane Street Group, LLC New York, NY45.3KShares$186,6150.0% of portfolio
-
State Street Corp Boston, MA24.3KShares$100,1770.0% of portfolio
-
Hrt Financial LP New York, NY21.5KShares$88,6580.0% of portfolio
-
Xtx Topco LTD London, X019.8KShares$81,7160.0% of portfolio
About Sonoma Pharmaceuticals, Inc.
- Ticker SNOA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,100,940
- Market Cap $12.8M
- Description
- Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...